semaglutide and cardiovascular outcomes in obesity without diabetes Beyond obesity: Novo's SELECT re-defines

Eli Lilly itself became the first trillion-dollar pharma company by market cap in 2026

This is not because patients dislike autoinjectors - evidence shows they generally don't mind and some prefer weekly dosing

This hormone plays a crucial role in: GLP-1 receptor agonists, like semaglutide (the active ingredient in Ozempic and Wegovy), mimic this hormone to amplify its effects

Although the exact etiology remains unclear, both UC and CD are thought to result from uncontrolled inflammation and immune dysregulation in genetically predisposed individuals [213]

Collaborators GBDAB

doi: 10.1038/s41598-018-20834-y 39 PangalosCThophileDSinetPMMarksAStamboulieh-AbazisDChettouhZet al